Eoflow invests 10.85B won in Gonjiam plant for automated insulin patch production line

Eoflow announced a 10.85 billion won investment in its Gonjiam production facility to build an automated production line for its Eopatch wearable insulin pump, including 3.75 billion won for plant expansion and 7.1 billion won for automation equipment. Completion is expected by December 2022.

“이오플로우는 곤지암 생산 시설에 대규모 투자를 진행한다고 3일 밝혔다.”medicaltimes.com

• 1 source
• medicaltimes.com[메디칼타임즈] 이오플로우, 곤지암 신공장 신규 시설 투자 결정Jun 3, 2022

Summarized from public sources; check the original articles before acting on it.